Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
2021 · Cell · 199 citations
https://doi.org/10.1016/j.cell.2021.01.035
A
Anna Z. Mykytyn
Erasmus MC(NL)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
58
Papers
4.2K
Citations
21
h-index
31
i10-index
Anna Z. Mykytyn is an academic researcher from Erasmus MC. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & Animal Virus Infections Studies. The author has an h-index of 21, co-authored 50 publications.
ORCID: 0000-0001-7188-6871Papers by this author
worksInterferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19
2021 · Journal of Clinical Immunology · 47 citations
https://doi.org/10.1007/s10875-021-01168-3
Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine
2022 · Cell Reports Medicine · 27 citations
https://doi.org/10.1016/j.xcrm.2022.100685
Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo-controlled clinical trial
2024 · The Lancet Infectious Diseases · 16 citations
https://doi.org/10.1016/s1473-3099(24)00423-7
Filamentous fungus-produced human monoclonal antibody provides protection against SARS-CoV-2 in hamster and non-human primate models
2024 · Nature Communications · 9 citations
https://doi.org/10.1038/s41467-024-46443-0
Variable DPP4 expression in multiciliated cells of the human nasal epithelium as a determinant for MERS-CoV tropism
2025 · Proceedings of the National Academy of Sciences · 7 citations
https://doi.org/10.1073/pnas.2410630122
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat